MITF and melanoma: In an elegant study by Kong et al. conducted in Peeper lab185, a CRISPR knock-out screen of melanoma cells resistant and addicted to BRAFi revealed a phenotypic switch dependent on ERK2 kinase and JUNB and FRA1 transcription factors accompanied by suppression of microphthalmia-associated transcription factor (MITF)185.